Home > Healthcare > Drug Device Combination > Uropathy Treatment Market

Uropathy Treatment Market Share

Report ID: GMI9581
Published Date: May 2024
Report Format: PDF

Download Free Sample

Uropathy Treatment Market Share

The market is characterized by the presence of several prominent players and a diverse range of products and services. Major companies operating in this market include pharmaceutical manufacturers, medical device companies, and service providers. These companies compete on various fronts such as product innovation, pricing strategies, geographical expansion, and strategic collaborations. Additionally, partnerships with healthcare facilities and academic institutions for research and development further contribute to market competitiveness.

Uropathy Treatment Market Companies

Some of the prominent players operating in the uropathy treatment industry include:

Astellas Pharma Inc.
B. Braun Melsungen AG
Becton, Dickinson, and Company
Boston Scientific Corporation
Cook Medical
Glaxo SmithKline Pharmaceuticals Ltd.
Inceler Medikal Co. Ltd.
KARL STORZ
Purdue Pharma
Olympus America
Pfizer Inc.
Sun Pharmaceutical Industries Europe B.V.
Synthon BV
Teleflex Incorporated.
UROMED Kurt Drews KG

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The uropathy treatment market size was valued at USD 4.7 billion in 2023 and is estimated to grow at 4.1% CAGR from 2024 – 2032, driven by the increasing incidence of urinary tract disorders, such as urinary tract infections (UTIs).

The hospitals end-use segment of the market will account for USD 1.8 billion by 2032, owing to specialized urology departments furnished with advanced technologies and staffed by skilled multidisciplinary teams.

U.S. uropathy treatment market size was USD 1.9 billion in 2023 and will grow rapidly through 2032, driven by the increasing prevalence of urological disorders, including the rising occurrence of urinary retention within the population.

Astellas Pharma Inc., B. Braun Melsungen AG, Becton, Dickinson, and Company, Boston Scientific Corporation, Cook Medical, Glaxo SmithKline Pharmaceuticals Ltd., Inceler Medikal Co. Ltd., KARL STORZ, Purdue Pharma, Olympus America, and Pfizer Inc. among others.